» Articles » PMID: 36685900

Functional Impact of Multi-omic Interactions in Breast Cancer Subtypes

Overview
Journal Front Genet
Date 2023 Jan 23
PMID 36685900
Authors
Affiliations
Soon will be listed here.
Abstract

Multi-omic approaches are expected to deliver a broader molecular view of cancer. However, the promised mechanistic explanations have not quite settled yet. Here, we propose a theoretical and computational analysis framework to semi-automatically produce network models of the regulatory constraints influencing a biological function. This way, we identified functions significantly enriched on the analyzed omics and described associated features, for each of the four breast cancer molecular subtypes. For instance, we identified functions sustaining over-representation of invasion-related processes in the basal subtype and DNA modification processes in the normal tissue. We found limited overlap on the omics-associated functions between subtypes; however, a startling feature intersection within subtype functions also emerged. The examples presented highlight new, potentially regulatory features, with sound biological reasons to expect a connection with the functions. Multi-omic regulatory networks thus constitute reliable models of the way omics are connected, demonstrating a capability for systematic generation of mechanistic hypothesis.

Citing Articles

Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors.

Rojas-Salazar Y, Gomez-Montanez E, Rojas-Salazar J, Anda-Jauregui G, Hernandez-Lemus E Int J Mol Sci. 2024; 25(23).

PMID: 39684551 PMC: 11641395. DOI: 10.3390/ijms252312840.


Coordinated inflammation and immune response transcriptional regulation in breast cancer molecular subtypes.

Velazquez-Caldelas T, Zamora-Fuentes J, Hernandez-Lemus E Front Immunol. 2024; 15:1357726.

PMID: 38983850 PMC: 11231215. DOI: 10.3389/fimmu.2024.1357726.


Functional impact of multi-omic interactions in lung cancer.

Diaz-Campos M, Vasquez-Arriaga J, Ochoa S, Hernandez-Lemus E Front Genet. 2024; 15:1282241.

PMID: 38389572 PMC: 10881857. DOI: 10.3389/fgene.2024.1282241.


Molecular mechanisms of multi-omic regulation in breast cancer.

Ochoa S, Hernandez-Lemus E Front Oncol. 2023; 13:1148861.

PMID: 37564937 PMC: 10411627. DOI: 10.3389/fonc.2023.1148861.


Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways.

Southekal S, Shakyawar S, Bajpai P, Elkholy A, Manne U, Mishra N Cancers (Basel). 2023; 15(7).

PMID: 37046795 PMC: 10093233. DOI: 10.3390/cancers15072134.

References
1.
Matic I, van Hagen M, Schimmel J, Macek B, Ogg S, Tatham M . In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics. 2007; 7(1):132-44. PMC: 3840926. DOI: 10.1074/mcp.M700173-MCP200. View

2.
Zheng G, Tu K, Yang Q, Xiong Y, Wei C, Xie L . ITFP: an integrated platform of mammalian transcription factors. Bioinformatics. 2008; 24(20):2416-7. DOI: 10.1093/bioinformatics/btn439. View

3.
Tam S, Tsao M, McPherson J . Optimization of miRNA-seq data preprocessing. Brief Bioinform. 2015; 16(6):950-63. PMC: 4652620. DOI: 10.1093/bib/bbv019. View

4.
Arif M, Zhang C, Li X, Gungor C, Cakmak B, Arslanturk M . iNetModels 2.0: an interactive visualization and database of multi-omics data. Nucleic Acids Res. 2021; 49(W1):W271-W276. PMC: 8262747. DOI: 10.1093/nar/gkab254. View

5.
He C, Imai M, Song H, Quigg R, Tomlinson S . Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol. 2005; 174(9):5750-7. DOI: 10.4049/jimmunol.174.9.5750. View